Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Pengyu Chang"'
Publikováno v:
Energies, Vol 17, Iss 18, p 4718 (2024)
With increasing dual pressure from global large energy consumption and environmental protection, multiple integrated energy systems (IESs) can provide more effective ways to achieve better energy utilization performance. However, in actual circumstan
Externí odkaz:
https://doaj.org/article/4dc5b972daed42a593ec56be36514170
Radiation enteropathy‐related depression: A neglectable course of disease by gut bacterial dysbiosis
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Radiation enteropathy (RE) is common in patients treated with radiotherapy for pelvic–abdominal cancers. Accumulating data indicate that gut commensal bacteria determine intestinal radiosensitivity. Radiotherapy can result in gut bacterial
Externí odkaz:
https://doaj.org/article/4e99412496f140d8803dde880c861593
Autor:
Zijing Liu, Tiankai Xu, Pengyu Chang, Weijia Fu, Jiaying Wei, Chengcheng Xia, Qiang Wang, Man Li, Xiaoyu Pu, Fuxue Huang, Chao Ge, Yan Gao, Shouliang Gong, Chengjiang Liu, Lihua Dong
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background and purpose: Although immune checkpoint inhibitors (ICIs) have become the first-line treatment for metastatic non-small cell lung cancer (mNSCLC), their efficacy is limited. Meanwhile, recent reports suggest that radiotherapy (RT) can acti
Externí odkaz:
https://doaj.org/article/cd8a562be1b64ddca24558532c28f755
Autor:
Kewen He, Shaotong Zhang, Jiaohui Pang, Jiani C. Yin, Dianbin Mu, Jun Wang, Hong Ge, Jie Ma, Zhe Yang, Xiaoli Zheng, Lihua Dong, Junli Zhang, Pengyu Chang, Li Li, Shanshan Tang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Jinming Yu, Shuanghu Yuan
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Chemo-radiotherapy (CRT) remains the main treatment modality for non-small-cell lung cancer (NSCLC). However, its clinical efficacy is largely limited by individual variations in radio-sensitivity and radiotherapy-associated toxicity. There is an urg
Externí odkaz:
https://doaj.org/article/a0dd551935594dbabb68acd34fac138b
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Lung adenocarcinomas exhibit various patterns of genomic alterations. During the development of this cancer, KRAS serves as a driver oncogene with a relatively high mutational frequency. Emerging data suggest that lung adenocarcinomas with KRAS mutat
Externí odkaz:
https://doaj.org/article/f92cf15fe40d4f08b7c460546455d7fc
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 131, Iss , Pp 110674- (2020)
Th17 cells are critical members in mediating immune responses of adaptive immunity. In humans and mice, gut is a main site where Th17 cells are resided, and Th17 cell polarization also occurs in the gut. This process can be mediated by many factors,
Externí odkaz:
https://doaj.org/article/ae39c5cd793b4675b5471bece34d5399
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Colorectal cancer occurrence and progression involve multiple aspects of host immune deficiencies. In these events, immune cells vary their phenotypes and functions over time, thus enabling the immune microenvironment to be “tumor-inhibiting” as
Externí odkaz:
https://doaj.org/article/52d4e4e918a7453499692030ff2e4eb6
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Immunotherapy using immune checkpoint inhibitors has opened a new era for cancer management. In colorectal cancer, patients with a phenotype of deficient mismatch repair or high microsatellite instability benefit from immunotherapy. However, the resp
Externí odkaz:
https://doaj.org/article/154084074d8c4e10a5be5f2432f489b9
Publikováno v:
Stem Cell Research & Therapy, Vol 9, Iss 1, Pp 1-7 (2018)
Abstract Since radiotherapy is widely used in managing thoracic tumors, physicians have begun to realize that radiation-induced lung injury (RILI) seriously limits the effects of radiotherapy. Unfortunately, there are still no effective methods for c
Externí odkaz:
https://doaj.org/article/e1ab3761adaf4478be5060737391ab3d
Publikováno v:
Cells, Vol 10, Iss 1, p 42 (2020)
Radiation-induced damage is a common occurrence in cancer patients who undergo radiotherapy. In this setting, radiation-induced damage can be refractory because the regeneration responses of injured tissues or organs are not well stimulated. Mesenchy
Externí odkaz:
https://doaj.org/article/3b6456acfd814f74a3d9f90f4a9c8106